Functional cure for hepatitis B in HIV/HBV co-infection
Treatments studied
Part of Digestive system, Immune system & allergy, Infections clinical trials.
This trial tests whether people with both HIV and hepatitis B can achieve a functional cure for hepatitis B. It aims to see if current treatment can be stopped safely after the hepatitis B virus is no longer active.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have both HIV and hepatitis B, with hepatitis B surface antigen (HBsAg) positive for at least 6 months.
- You have been on HIV treatment (ART) for at least 1 year and are still on it.
- Your hepatitis B virus level (HBV DNA) is very low - not detectable at a sensitive test.
- Your HIV is well-controlled with less than 20 copies/mL and your CD4 count is above 200 cells/μL.
- You do not have active hepatitis A, C, D, or E, serious liver disease, autoimmune disorders, cancer, or other major health problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether pegylated interferon can help people with inactive chronic hepatitis B stay stable or improve outcomes. You may qualify if your virus levels and liver blood tests are currently low and you’ve never used antiviral treatments.
This Phase 2 trial studies an injection (HRS-5635), either alone or with other medicines, to see if it is safe and helps keep chronic hepatitis B under control. It is for people who are already on standard hepatitis B antivirals and have low or undetectable viral levels.
This trial tests if peginterferon alfa-2b can help children with chronic hepatitis B achieve a functional cure. If your child has had hepatitis B for a while and still has the virus in their blood, this study might be an option.
This study tests whether additional peginterferon treatment can further reduce the virus in the liver for people with chronic hepatitis B who have already reached a clinical cure. You would need to have two liver biopsies to check the virus levels.
This trial tests whether combining ASC22 with peginterferon can help people with chronic hepatitis B achieve a functional cure (clearing the virus for good). It's for patients whose HBsAg levels are very low and who are already on stable treatment.
This Phase 2 study tests a combination treatment to help people with chronic hepatitis B stop having detectable hepatitis B surface antigen (called HBsAg). If successful, it may move you closer to a “functional cure,” meaning lower ongoing virus activity over time.
Hear when a new AIDS trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.